Clinical Trial

The Choice of Treatment Methods and Efficacy of LABC

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated October 12, 2023 (before its estimated October 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to compare the therapeutic effects of chemotherapy followed by surgery and surgery followed by chemotherapy in patients with locally advanced breast cancer（LABC). Patients with LABC will be randomly divided into two groups, each receiving chemotherapy followed by surgery or surgery followed by chemotherapy. The main comparison was between the disease-free survival (DFS) of two groups of patients, with the secondary study endpoint being overall survival (OS); Five year survival; Local recurrence or distant metastasis rate.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-09
Trial Details
NCT Number NCT06080620
Lead Sponsor Peking Union Medical College Hospital
Conditions Locally Advanced Breast Cancer
Enrollment 50 participants
Start Date 2023-10-08
Primary Completion 2025-10-01 (estimated)
Study Completion 2026-08-01 (estimated)
Updated on ClinicalTrials.gov 2023-10-12